Pharmaron Beijing Co., Ltd. (PHBBF)
1.93
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Pharmaron Beijing Net Income (Quarterly) : 58.95M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 58.95M |
| March 31, 2026 | 44.83M |
| December 31, 2025 | 69.01M |
| September 30, 2025 | 57.74M |
| June 30, 2025 | 51.56M |
| March 31, 2025 | 38.43M |
| December 31, 2024 | 47.98M |
| September 30, 2024 | 39.94M |
| June 30, 2024 | 119.72M |
| March 31, 2024 | 30.04M |
| December 31, 2023 | 61.87M |
| September 30, 2023 | 48.36M |
| June 30, 2023 | 61.81M |
| March 31, 2023 | 51.18M |
| December 31, 2022 | 57.33M |
| September 30, 2022 | 55.28M |
| June 30, 2022 | 49.65M |
| Date | Value |
|---|---|
| March 31, 2022 | 37.32M |
| December 31, 2021 | 96.37M |
| September 30, 2021 | 70.59M |
| June 30, 2021 | 48.10M |
| March 31, 2021 | 36.53M |
| December 31, 2020 | 57.46M |
| September 30, 2020 | 43.30M |
| June 30, 2020 | 52.69M |
| March 31, 2020 | 13.35M |
| December 31, 2019 | 30.26M |
| September 30, 2019 | 22.92M |
| June 30, 2019 | 15.29M |
| March 31, 2019 | 7.732M |
| December 31, 2018 | 16.57M |
| September 30, 2018 | 15.93M |
| June 30, 2018 | 12.88M |
| March 31, 2018 | 6.234M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Viva Biotech Holdings | -- |
| ICON plc | 72.58M |
| Proteome Sciences Plc | -- |
| Champions Oncology, Inc. | -0.667M |
| SPO Global, Inc. | -0.0067M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 590.13M |
| Total Expenses (Quarterly) | 529.18M |
| EPS Diluted (Quarterly) | 0.0332 |
| Enterprise Value | 4.313B |
| Gross Profit Margin (Quarterly) | 31.01% |
| Profit Margin (Quarterly) | 9.99% |
| Earnings Yield | 7.06% |
| Operating Earnings Yield | 8.85% |
| Normalized Earnings Yield | 6.762 |